During the Covid-19 pandemic, telehealth was all the rage. And in the years since, artificial intelligence (AI) has set the healthcare world on fire.

In fact, market research and consulting company Grand View Research reported that AI in healthcare was a $19.3 billion industry in 2023. But by 2030, the consultancy expects that figure to reach $187.7 billion.

In a partnership announced on October 22, videoconferencing software company Zoom and ambient listening AI company Suki are looking to join forces. During medical appointments using Zoom, Punit Soni, founder and CEO of Suki, said Suki’s ambient listening tech can take notes for clinicians to review after appointments once clinicians get patient consent and click it on. It also works during in-person appointments as well, he said, improving continuity of care.

Notes can encompass the purpose of the visit, the clinician’s assessment, the diagnosis, and applicable billing codes, according to Soni.

Keep reading here.—CM

The ticket to scoring your dream job lies in your resume. If the doc containing all of your work experience is lacking, your job search is probably following suit.

Need help polishing up yours? Indeed can do just that. In fact, Indeed Careers in Care, their job search guidance branch, offers an Instant Resume Report, a game-changing review feature that gives you immediate, actionable, and personalized advice to help transform your resume for the better.

How’s it work? All you’ve gotta do is upload a resume—or select your Indeed resume—and voilà! Expertly guided AI will review your doc. You can even fork over a few bucks to have a professional resume reviewer give it a run-through.

Level up your resume.

Need an inflatable unicorn pool float and prescription cough medicine delivered to your home? Walmart’s now got you covered.

The retail giant announced it is rolling out Pharmacy Delivery, a service that delivers new prescriptions and medication refills with groceries and whatever else you impulsively added to your cart.

The new service is up and running in six states—Arkansas, Missouri, New York, Nevada, South Carolina, and Wisconsin—with plans to reach 49 states by the end of January 2025.

This puts the chain on par with drugstore giants like CVS and Walgreens, where each offers same-day, one-day, and two-day drug delivery options.

But while CVS Health and Walgreens stocks are tanking this quarter, Monday’s announcement sent Walmart’s stock soaring toward towering heights, reaching nearly $83 a share on Wednesday.

Keep reading here.—CC

Amid the lingering effects of the Medicaid unwinding, insurance companies are posting bleak Q3 earnings reports—except, that is, for Centene Corporation, the nation’s largest Medicaid provider.

The company’s Q3 performance beat previous expectations with $1.62 earnings per share (EPS), CFO Drew Asher said in an October 25 earnings call. This is above the $1.41 average that Wall Street analysts had estimated, Bloomberg reported.

Other Medicaid providers have been hit hard after the unwinding removed millions of members from the rolls. But Centene weathered the crisis, buffered by its other plans.

Even as it saw Medicaid enrollment shrink from more than 15 million in September 2023 to around 13 million in September 2024 in the 30 states it operates in, Centene’s Medicare Part D enrollment grew by more than 2 million and commercial marketplace enrollment grew by more than 1 million, according to an October 25 press release.

“The team’s diversified portfolio continues to allow us to navigate unprecedented landscape challenges,” CEO Sarah London said during the earnings call.

Keep reading here.—CC